MSGR – Direxion mRNA ETF

Direxion mRNA ETF (MSGR) is a Health ETF, issued by Direxion, $3.1M in assets, 0.65% expense ratio.

Returns as of Oct 28, 2026: 1 week -97.2%, 1 year -6.6%.

Focuses on companies developing mRNA technology, investing in securities from the U.S., Canada, and Europe.